SYRE Cash & Short-Term Investments

Spyre Therapeutics Inc · Cash & Short-Term Investments

SYRE logo

SYRE Cash & Short-Term Investments

Latest reported$756.53M
SYRE FY Cash & Short-Term Investments ($4.60M → $756.53M)
High-resolution chart · PNG

SYRE cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
756,533,000
603,088,000
339,277,000
55,711,000
93,128,000
146,273,000
71,949,000
74,513,000
50,299,000
63,502,000
33,062,000
2,616,000
4,597,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.